Advanced Glycation End Products (AGE) and Diabetes: Cause, Effect, or Both?
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advanced Glycation End Products (AGE) and Diabetes: Cause, Effect, or Both?
Authors
Keywords
AGE-receptors, AGER1, SIRT1, Glycation, Oxidation, Diet, Inflammation, Innate immunity
Journal
Current Diabetes Reports
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-11-28
DOI
10.1007/s11892-013-0453-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Sevelamer on HbA1c, Inflammation, and Advanced Glycation End Products in Diabetic Kidney Disease
- (2012) H. Vlassara et al. Clinical Journal of the American Society of Nephrology
- Glycotoxin and Autoantibodies Are Additive Environmentally Determined Predictors of Type 1 Diabetes
- (2012) Huriya Beyan et al. DIABETES
- Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1
- (2012) W. Cai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Advanced Glycation End Products Are Direct Modulators of -Cell Function
- (2011) M. T. Coughlan et al. DIABETES
- Restriction of Advanced Glycation End Products Improves Insulin Resistance in Human Type 2 Diabetes: Potential role of AGER1 and SIRT1
- (2011) J. Uribarri et al. DIABETES CARE
- AGE restriction in diabetes mellitus: a paradigm shift
- (2011) Helen Vlassara et al. Nature Reviews Endocrinology
- Maternally Transmitted and Food-Derived Glycotoxins: A factor preconditioning the young to diabetes?
- (2010) V. Mericq et al. DIABETES CARE
- Advanced Glycation End Products in Foods and a Practical Guide to Their Reduction in the Diet
- (2010) Jaime Uribarri et al. JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Advanced Glycation End Product Receptor-1 Transgenic Mice Are Resistant to Inflammation, Oxidative Stress, and Post-Injury Intimal Hyperplasia
- (2009) Massimo Torreggiani et al. AMERICAN JOURNAL OF PATHOLOGY
- AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-δ: implications for vascular disease
- (2009) Weijing Cai et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Advanced Glycation End Products Inhibit Glucose-Stimulated Insulin Secretion through Nitric Oxide-Dependent Inhibition of CytochromecOxidase and Adenosine Triphosphate Synthesis
- (2009) Zhengshan Zhao et al. ENDOCRINOLOGY
- Protection against Loss of Innate Defenses in Adulthood by Low Advanced Glycation End Products (AGE) Intake: Role of the Antiinflammatory AGE Receptor-1
- (2009) Helen Vlassara et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
- (2009) Jay S. Skyler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging
- (2009) Helen Vlassara et al. KIDNEY INTERNATIONAL
- Oral Glycotoxins Determine the Effects of Calorie Restriction on Oxidant Stress, Age-Related Diseases, and Lifespan
- (2008) Weijing Cai et al. AMERICAN JOURNAL OF PATHOLOGY
- The RAGE Pathway
- (2008) Ivan K. Lukic et al. Annals of the New York Academy of Sciences
- Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
- (2008) William Duckworth et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search